Philip Spanheimer, MD (he/him/his)

Attending
University of North Carolina, North Carolina, United States

I am a surgical oncologist at the University of North Carolina in Cnapel Hill. My clinical practice focuses on patients with bresat cancer and sarcoma. I also have a translational research lab where we develop clinically relevant cancer models and study how breast tumors respond to therapy. In particular we are interested in how cancer cells change how genes are regualted to become resistant to therapy and use this to identify therapeutic vulnerabilities of reprogrammed gene expression..

Presentation(s):

• 34: High Tumor Grade Predicts Somatic/Germline RET Mutation Status and Greater Regional Lymph Node Burden in Medullary Thyroid Carcinoma

  Friday, March 22, 2024
  1:38pm – 1:50pm ET

• 13: Predictors of Nodal Clearance After Neoadjuvant Chemotherapy in Breast Cancer

  Saturday, March 23, 2024
  8:10am – 8:20am ET

• Breast Poster Presentations 2

  Saturday, March 23, 2024
  10:00am – 10:30am ET